Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPAN: S-1 + Liposomal Irinotecan vs 5-FU + Liposomal Irinotecan in Metastatic Pancreatic Cancer
NCT03986294Phase 2Unknown
- Sponsor
- University of Amsterdam
- Start
- Dec 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in pancreatic adenocarcinoma (PDAC), sponsored by University of Amsterdam. Status: unknown.
02
Drugs
tegafur
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03986294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03986294.